Cuprina Stock Faces a Nasdaq Clock After Reverse Split—What Comes Next
Cuprina Holdings Limited heads into the new week with its Nasdaq listing still in play after a rough Friday close. The Singapore-based biomedical company’s Class A shares finished at $2.40 on May 29, down 27.27%, the company’s stock page showed. Why it matters now: Cuprina said Nasdaq staff had determined the company’s securities would be scheduled for delisting after it failed to regain compliance with the $1.00 minimum bid price rule, an exchange requirement tied to the price buyers are willing to pay for a stock. The firm said it filed a hearing request on May 28, which keeps the shares trading while a Nasdaq Hearings Panel reviews the case.